Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eiger BioPharmaceuticals Inc (NASDAQ:EIGR)

20.80
Delayed Data
As of May 27
 +0.74 / +3.69%
Today’s Change
12.90
Today|||52-Week Range
39.75
-5.67%
Year-to-Date
No recent news for Eiger BioPharmaceuticals Inc.

Today’s Trading

Previous close20.06
Today’s open20.00
Day’s range20.00 - 20.94
Volume45,736
Average volume (3 months)9,939
Market cap$144.5M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-61.48%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.45

Competitors

 Today’s
change
Today’s
% change
ANTHAnthera Pharmaceutic...-0.05-1.41%
EGLTEgalet Corp+0.35+6.59%
ADHDAlcobra Ltd+0.10+1.99%
RDHLRedhill Biopharma Lt...+0.04+0.36%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.99
Annual revenue (last year)$0.00
Annual profit (last year)-$33.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David A. Cory
Chief Financial Officer
James H. Welch
Corporate headquarters
Palo Alto, California

Forecasts

Partner Offers

Search for Jobs